# Bajaj Healthcare (NSE: BAJAJHCARE) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/BAJAJHCARE · Pivot · prices to 22 Oct 2026

Bajaj Healthcare (NSE: BAJAJHCARE) closed at ₹327.65 on 22 Oct 2026, up 1.13% on the day. With a market capitalisation of ₹1,103 Cr, it ranks 1407th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

At its last close the stock traded at 48.6× trailing earnings, against a return on equity of 8.5% in FY25. Over the past year the share price has fallen 28.5%. Its 52-week range is ₹272.35 (18 May 2026) to ₹488.90 (30 Oct 2025); the last close is 33.0% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹166 Cr (+11.3% year on year) and net profit ₹14 Cr (+15.8%), on a standalone basis. Promoters held 58.59% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹327.65 |
| Market cap | ₹1,103 Cr |
| P/E (trailing) | 48.6 |
| ROE | 8.5% (FY25) |
| ROCE | 13.8% (FY25) |
| Debt to equity | 0.48 |
| 52-week high | ₹488.90 (30 Oct 2025) |
| 52-week low | ₹272.35 (18 May 2026) |
| 1-year return | −28.5% |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹166 Cr | +11.3% | ₹14 Cr | +15.8% | ₹4.07 |
| Q4 FY26 | ₹153 Cr | −0.9% | −₹23 Cr | −304.4% | −₹7.16 |
| Q3 FY26 | ₹161 Cr | +31.3% | ₹16 Cr | +33.7% | ₹4.96 |
| Q2 FY26 | ₹148 Cr | +11.1% | ₹11 Cr | +17.4% | ₹3.53 |
| Q1 FY26 | ₹149 Cr | +12.5% | ₹12 Cr | +65.9% | ₹3.74 |
| Q4 FY25 | ₹154 Cr | +15.4% | ₹11 Cr | — | ₹3.54 |
| Q3 FY25 | ₹123 Cr | +13.1% | ₹12 Cr | — | ₹3.65 |
| Q2 FY25 | ₹133 Cr | +31.5% | ₹9 Cr | — | ₹3.36 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹543 Cr | ₹40 Cr |
| FY24 | ₹473 Cr | −₹84 Cr |
| FY23 | ₹673 Cr | ₹43 Cr |
| FY22 | ₹680 Cr | ₹71 Cr |
| FY21 | ₹657 Cr | ₹83 Cr |
| FY20 | ₹410 Cr | ₹23 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 58.59%
- Foreign institutions: 2.19%
- Domestic institutions: 1.92%
- Non-institutions: 37.30%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Shalby](https://app.pivotnow.in/stock/SHALBY) | ₹118.16 | ₹1,276 Cr | 36.5 | — |
| [GPT Healthcare](https://app.pivotnow.in/stock/GPTHEALTH) | ₹135.22 | ₹1,110 Cr | 26.3 | — |
| [Bafna Pharmaceuticals](https://app.pivotnow.in/stock/BAFNAPH) | ₹451.95 | ₹1,069 Cr | 96.4 | — |
| [Lincoln Pharmaceuticals](https://app.pivotnow.in/stock/LINCOLN) | ₹517.50 | ₹1,037 Cr | 11.8 | — |
| [Sigachi Industries](https://app.pivotnow.in/stock/SIGACHI) | ₹26.24 | ₹1,003 Cr | — | — |
| [Laxmi Dental](https://app.pivotnow.in/stock/LAXMIDENTL) | ₹177.55 | ₹976 Cr | 33.7 | — |

## Questions and answers

### What is the share price of Bajaj Healthcare today?

Bajaj Healthcare (NSE: BAJAJHCARE) last closed at ₹327.65 on 22 Oct 2026. Its 52-week high is ₹488.90 and its 52-week low is ₹272.35.

### What is the market cap of Bajaj Healthcare?

Bajaj Healthcare's market capitalisation is ₹1,103 Cr (₹1,103 Cr) at the 22 Oct 2026 close, ranking 1407th among the NSE companies Pivot tracks.

### What is the P/E ratio of Bajaj Healthcare?

Bajaj Healthcare trades at a trailing P/E of 48.6. The median P/E of the 5 closest Pharma & Healthcare peers by market cap is 33.7.

### What is the ROE and ROCE of Bajaj Healthcare?

Return on equity was 8.5% in FY25 and return on capital employed was 13.8% in FY25 (standalone figures).

### Is Bajaj Healthcare a debt-free company?

No. Bajaj Healthcare's debt-to-equity ratio was 0.48 in FY25, with total debt of ₹65 Cr.

### What were Bajaj Healthcare's latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), Bajaj Healthcare reported revenue of ₹166 Cr, +11.3% year on year, and net profit of ₹14 Cr, +15.8% year on year.

### How has Bajaj Healthcare stock performed over the last year?

Bajaj Healthcare's share price has fallen 28.5% over the past year, +1.8% over three months and −2.1% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Bajaj Healthcare?

As of 30 Jun 2026: promoters 58.59%, foreign institutions 2.19%, domestic institutions 1.92%, non-institutions 37.30%.

### Who are Bajaj Healthcare's competitors?

The listed Pharma & Healthcare companies closest to Bajaj Healthcare by market cap are Shalby, GPT Healthcare, Bafna Pharmaceuticals, Lincoln Pharmaceuticals, Sigachi Industries and Laxmi Dental.

### Is Bajaj Healthcare a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Bajaj Healthcare's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on BAJAJHCARE against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.